GOCO - GoHealth, Inc.
NASDAQ
->
Financial Services
->
Insurance Brokers
Chicago,
United States
Type: Equity
GOCO price evolution
GOCO
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $14.12 | $97.82 | $90.81 | |
| Short term investments | ||||
| Net receivables | $277.25 | $828.52 | $852.35 | $911.95 |
| Inventory | ||||
| Total current assets | $334.04 | $301.17 | $397.1 | $476.44 |
| Long term investments | ||||
| Property, plant & equipment | $50.87 | $49.84 | $49.67 | $48.84 |
| Goodwill & intangible assets | $349.53 | $373.04 | $396.55 | |
| Total noncurrent assets | $955.9 | $998.16 | $1023.13 | |
| Total investments | ||||
| Total assets | $1341.15 | $1257.08 | $1395.26 | $1499.57 |
| Current liabilities | ||||
| Accounts payable | $15.29 | $285.44 | $302.32 | $339.69 |
| Deferred revenue | $27.81 | $38.72 | $52.4 | |
| Short long term debt | $44.85 | $80.31 | $80.8 | |
| Total current liabilities | $281.97 | $234.04 | $300 | $370.01 |
| Long term debt | $416.33 | $450.15 | $448.52 | $462.25 |
| Total noncurrent liabilities | $695.24 | $709.62 | $723.9 | |
| Total debt | $495 | $528.83 | $543.05 | |
| Total liabilities | $1077.09 | $929.28 | $1009.62 | $1093.92 |
| Shareholders' equity | ||||
| Retained earnings | -$448.72 | -$455.49 | -$429.5 | -$420.28 |
| Other shareholder equity | -$0.14 | -$0.15 | -$0.13 | -$0.13 |
| Total shareholder equity | $202.73 | $225.88 | $231.01 | |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $90.81 | $16.46 | $84.36 | $144.23 |
| Short term investments | ||||
| Net receivables | $911.95 | $340.5 | $1279.78 | $840.66 |
| Inventory | ||||
| Total current assets | $476.44 | $414.56 | $429 | $391.82 |
| Long term investments | ||||
| Property, plant & equipment | $48.84 | $46.77 | $47.73 | $17.35 |
| Goodwill & intangible assets | $396.55 | $500.61 | $594.67 | $1075.28 |
| Total noncurrent assets | $1023.13 | $1244.73 | $1639.86 | $1716.97 |
| Total investments | ||||
| Total assets | $1499.57 | $1659.29 | $2068.85 | $2108.8 |
| Current liabilities | ||||
| Accounts payable | $339.69 | $15.15 | $418.41 | $269.81 |
| Deferred revenue | $52.4 | $50.59 | $0.54 | $0.74 |
| Short long term debt | $80.8 | $14.24 | $11.4 | $4.17 |
| Total current liabilities | $370.01 | $265.45 | $217.07 | $127.37 |
| Long term debt | $462.25 | $504.81 | $684.89 | $396.4 |
| Total noncurrent liabilities | $723.9 | $851.44 | $959.29 | $582.27 |
| Total debt | $543.05 | $557.42 | $696.29 | $400.57 |
| Total liabilities | $1093.92 | $1341.23 | $1176.36 | $709.64 |
| Shareholders' equity | ||||
| Retained earnings | -$420.28 | -$357.02 | -$208.32 | -$18.8 |
| Other shareholder equity | -$0.13 | -$0.14 | -$0.06 | $0.02 |
| Total shareholder equity | $231.01 | $268.76 | $353.1 | $380.42 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $105.87 | $185.6 | $276.7 | |
| Cost of revenue | $20.68 | $38.01 | $41.09 | |
| Gross Profit | $85.19 | $147.59 | $235.61 | |
| Operating activities | ||||
| Research & development | $8.57 | $10.55 | $11.6 | |
| Selling, general & administrative | $54.4 | $69.69 | $100.24 | |
| Total operating expenses | $125.8 | $151.62 | $220.55 | |
| Operating income | -$40.61 | -$4.03 | $15.06 | |
| Income from continuing operations | ||||
| EBIT | -$7.94 | $8.66 | $16.9 | |
| Income tax expense | -$0.04 | -$0.07 | $0.38 | |
| Interest expense | $18.1 | $17.95 | $17.75 | |
| Net income | ||||
| Net income | -$26 | -$9.22 | -$1.23 | |
| Income (for common shares) | -$26 | -$9.22 | -$1.23 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $734.67 | $631.67 | $1062.41 | $877.35 |
| Cost of revenue | $158.96 | $187.67 | $239.34 | $199.2 |
| Gross Profit | $575.71 | $444 | $823.08 | $678.15 |
| Operating activities | ||||
| Research & development | $43.3 | $46.09 | $48.43 | $59.35 |
| Selling, general & administrative | $298.11 | $324.09 | $463.32 | $404.09 |
| Total operating expenses | $657.39 | $762.67 | $1312.53 | $722.99 |
| Operating income | -$81.68 | -$318.67 | -$489.45 | -$44.85 |
| Income from continuing operations | ||||
| EBIT | $6.37 | -$90.87 | -$155.88 | -$11.26 |
| Income tax expense | $0.15 | $0.76 | -$0.02 | $0.04 |
| Interest expense | $69.47 | $57.07 | $33.51 | $32.97 |
| Net income | ||||
| Net income | -$63.26 | -$148.71 | -$189.36 | -$44.27 |
| Income (for common shares) | -$63.26 | -$148.71 | -$189.36 | -$44.27 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | -$26 | -$9.22 | -$1.23 | |
| Operating activities | ||||
| Depreciation | $27.3 | $27.23 | $27.78 | |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $1.89 | $1.78 | $4.25 | |
| Total cash flows from operations | -$36.5 | $12.51 | $71.3 | |
| Investing activities | ||||
| Capital expenditures | -$2.7 | -$4.56 | -$5.64 | |
| Investments | ||||
| Total cash flows from investing | $6.03 | -$2.7 | -$4.56 | -$5.64 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$0.39 | -$0.94 | -$0.2 | |
| Net borrowings | -$44.06 | |||
| Total cash flows from financing | -$25.06 | -$44.45 | -$0.94 | -$1.09 |
| Effect of exchange rate | -$0.03 | -$0.05 | -$0.01 | -$0.15 |
| Change in cash and equivalents | -$55.28 | -$83.69 | $7.01 | $64.42 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$63.26 | -$148.71 | -$189.36 | -$44.27 |
| Operating activities | ||||
| Depreciation | $109.76 | $111.02 | $112.54 | $98.55 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $19.55 | $27.14 | $27.3 | $216.23 |
| Total cash flows from operations | $109.14 | $60.9 | -$299.01 | -$114.22 |
| Investing activities | ||||
| Capital expenditures | -$13.73 | -$13.51 | -$19.8 | -$14.52 |
| Investments | ||||
| Total cash flows from investing | -$13.73 | -$13.51 | -$19.8 | -$14.52 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$2.2 | -$0.34 | $862.41 | |
| Net borrowings | -$15.34 | -$163.07 | $259.09 | $103.14 |
| Total cash flows from financing | -$21.11 | -$115.05 | $259.09 | $260.66 |
| Effect of exchange rate | $0.04 | -$0.24 | -$0.15 | $0.04 |
| Change in cash and equivalents | $74.34 | -$67.9 | -$59.87 | $131.96 |
News
Fundamentals
| Market cap | $232.85M |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 22.90M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 4.74 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 1.18 |
| Quick ratio | N/A |